Table 3.
Adverse event by injection-site category | Incidence (%) | ||
---|---|---|---|
Placebo | ATX-101 1 mg cm−2 | ATX-101 2 mg cm−2 | |
Pain including burning | 25·4 | 77·3 | 80·2 |
Swelling including oedema | 30·3 | 65·5 | 66·1 |
Bruising including bleeding | 41·0 | 55·5 | 53·7 |
Numbness | 2·5 | 47·9 | 51·2 |
Erythema | 23·0 | 38·7 | 37·2 |
Induration including fibrosis | 2·5 | 18·5 | 26·4 |